← Back
$CTNM All transactions

Contineum Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$56K

Shares

4,170

Price

$13

Filed

Apr 6

Insider

Name

Lorrain Daniel S.

Title

Chief Scientific Officer

CIK

0001861550

Roles

Officer

Transaction Details

Transaction Date

2026-04-06

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

147,712

Footnotes

These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.08 to $13.60, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Filing Info

Accession No.

0001628280-26-023949

Form Type

4

Issuer CIK

0001855175

Lorrain Daniel S.'s History

Date Ticker Type Value
2026-04-06 CTNM $56K

Other Insiders at CTNM (90d)

No other insider activity at this issuer in the last 90 days.